C.E. Davis
About
C.E. Davis is a scholar working on Endocrinology, Diabetes and Metabolism, Statistics and Probability and Public Health, Environmental and Occupational Health.
According to data from OpenAlex, C.E. Davis has authored 94 papers receiving a total of 12.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Endocrinology, Diabetes and Metabolism, 19 papers in Statistics and Probability and 17 papers in Public Health, Environmental and Occupational Health. Recurrent topics in C.E. Davis's work include Diabetes, Cardiovascular Risks, and Lipoproteins (22 papers), Lipoproteins and Cardiovascular Health (14 papers) and Statistical Methods in Clinical Trials (12 papers). C.E. Davis is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (22 papers), Lipoproteins and Cardiovascular Health (14 papers) and Statistical Methods in Clinical Trials (12 papers). C.E. Davis collaborates with scholars based in United States, Russia and Poland. C.E. Davis's co-authors include Sonia M. Davis, Jeffrey A. Lieberman, Robert A. Rosenheck, T. Scott Stroup, John Hsiao, Diana O. Perkins, Joanne B. Severe, Marvin S. Swartz, Joseph P. McEvoy and Richard S.E. Keefe and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.
In The Last Decade
C.E. Davis
92 papers receiving 11.9k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| C.E. Davis United States | 41 | 4.3k | 2.2k | 2.1k | 1.8k | 1.2k | 94 | 12.5k | ||
| Dimitris Mavridis Greece | 41 | 2.3k 0.5× | 1.2k 0.6× | 542 0.3× | 1.5k 0.9× | 1.1k 0.9× | 174 | 9.4k | ||
| Anton J.M. de Craen Netherlands | 68 | 2.4k 0.5× | 2.5k 1.1× | 1.6k 0.8× | 2.6k 1.5× | 2.5k 2.1× | 298 | 16.6k | ||
| Richard I. G. Holt United Kingdom | 47 | 2.2k 0.5× | 826 0.4× | 5.4k 2.6× | 879 0.5× | 2.0k 1.7× | 260 | 9.6k | ||
| Stefan N. Willich Germany | 61 | 1.4k 0.3× | 3.6k 1.7× | 392 0.2× | 2.3k 1.3× | 1.3k 1.1× | 360 | 15.5k | ||
| Charles Warlow United Kingdom | 73 | 2.3k 0.5× | 5.6k 2.6× | 338 0.2× | 1.6k 0.9× | 8.5k 7.1× | 236 | 19.8k | ||
| John E. Cornell United States | 46 | 1.3k 0.3× | 1.3k 0.6× | 398 0.2× | 1.4k 0.8× | 1.1k 0.9× | 112 | 8.6k | ||
| Jean‐François Dartigues France | 72 | 6.9k 1.6× | 1.3k 0.6× | 856 0.4× | 556 0.3× | 987 0.8× | 346 | 18.7k | ||
| Philip B. Gorelick United States | 65 | 2.8k 0.7× | 5.7k 2.6× | 957 0.5× | 2.1k 1.2× | 7.0k 5.8× | 305 | 18.8k | ||
| Kathleen Hall United States | 50 | 5.6k 1.3× | 733 0.3× | 407 0.2× | 650 0.4× | 857 0.7× | 107 | 12.0k | ||
| Wendy J. Mack United States | 74 | 3.1k 0.7× | 3.1k 1.4× | 5.1k 2.5× | 2.1k 1.2× | 1.7k 1.4× | 402 | 20.2k |
Countries citing papers authored by C.E. Davis
Since
Specialization
Citations
This map shows the geographic impact of C.E. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.E. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.E. Davis more than expected).
Fields of papers citing papers by C.E. Davis
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by C.E. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.E. Davis. The network helps show where C.E. Davis may publish in the future.
Co-authorship network of co-authors of C.E. Davis
This figure shows the co-authorship network connecting the top 25 collaborators of C.E. Davis. A scholar is included among the top collaborators of C.E. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.E. Davis. C.E. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Stroup, T. Scott, Jeffrey A. Lieberman, Joseph P. McEvoy, et al.. (2006). Effectiveness of Olanzapine, Quetiapine, Risperidone, and Ziprasidone in Patients With Chronic Schizophrenia Following Discontinuation of a Previous Atypical Antipsychotic. FOCUS The Journal of Lifelong Learning in Psychiatry. 4(4). 539–552.
2.
Stroup, T. Scott, Jeffrey A. Lieberman, Joseph P. McEvoy, et al.. (2006). Effectiveness of Olanzapine, Quetiapine, Risperidone, and Ziprasidone in Patients With Chronic Schizophrenia Following Discontinuation of a Previous Atypical Antipsychotic. American Journal of Psychiatry. 163(4). 611–622.
3.
Bang, Heejung & C.E. Davis. (2006). On estimating treatment effects under non‐compliance in randomized clinical trials: are intent‐to‐treat or instrumental variables analyses perfect solutions?. Statistics in Medicine. 26(5). 954–964.
4.
Ni, Liyun, et al.. (2005). Response to Henneicke-von-Zepelin and Harri Hemilä's comment. Contemporary Clinical Trials. 26(4). 514–515.
5.
Cai, Jianwen, Andrzej Pająk, Yihe Li, et al.. (2004). Total Cholesterol and Mortality in China, Poland, Russia, and the US. Annals of Epidemiology. 14(6). 399–408.
6.
Nv, Perova, C.E. Davis, Andrzej Pająk, et al.. (2001). Multi-country comparison of plasma lipid relationship to years of schooling in men and women. International Journal of Epidemiology. 30(2). 371–379.
7.
Metcalf, Patricia, Aaron R. Folsom, C.E. Davis, Kenneth K. Wu, & Gerardo Heiss. (2000). Haemostasis and carotid artery wall thickness in non-insulin dependent diabetes mellitus. Diabetes Research and Clinical Practice. 47(1). 25–35.
8.
Carpenter, Myra A., Melvyn S. Tockman, Richard G. Hutchinson, C.E. Davis, & Gerardo Heiss. (1999). Demographic and Anthropometric Correlates of Maximum Inspiratory Pressure: The Atherosclerosis Risk in Communities Study. American Journal of Respiratory and Critical Care Medicine. 159(2). 415–422.
9.
Metcalf, P A, June Stevens, Tomoko Shimakawa, et al.. (1998). Comparison of diets of NIDDM and non-diabetic African Americans and whites: The atherosclerosis risk in communities study. Nutrition Research. 18(3). 447–456.
10.
Knatterud, Genell L., Frank W. Rockhold, Stephen L. George, et al.. (1998). Guidelines for Quality Assurance in Multicenter Trials. Controlled Clinical Trials. 19(5). 477–493.
11.
Rywik, S, et al.. (1998). Poland and U.S. Collaborative Study on Cardiovascular Epidemiology Hypertension in the Community: Prevalence, Awareness, Treatment, and Control of Hypertension in the Pol-MONICA Project and the U.S. Atherosclerosis Risk in Communities Study. Annals of Epidemiology. 8(1). 3–13.
12.
Davis, C.E.. (1997). Secondary endpoints can be validly analyzed, even if the primary endpoint does not provide clear statistical significance. Controlled Clinical Trials. 18(6). 557–560.
13.
Davis, C.E., et al.. (1994). Correlates of Mortality in Russian and US Women. American Journal of Epidemiology. 139(4). 369–379.
14.
Деев, А. Д., et al.. (1993). Increased risk of coronary heart disease death in men with low total and low-density lipoprotein cholesterol in the Russian Lipid Research Clinics Prevalence Follow-up Study.. Circulation. 88(3). 846–853.
15.
Criqui, Michael H., Gerardo Heiss, Richard D. Cohn, et al.. (1993). Plasma Triglyceride Level and Mortality from Coronary Heart Disease. New England Journal of Medicine. 328(17). 1220–1225.
16.
Wu, Kenneth K., Aaron R. Folsom, Gerardo Heiss, et al.. (1992). Association of coagulation factors and inhibitors with carotid artery atherosclerosis early results of the Atherosclerosis Risk in Communities (ARIC) study. Annals of Epidemiology. 2(4). 471–480.
17.
Patsch, Wolfgang, A. Richey Sharrett, Paul D. Sorlie, C.E. Davis, & Spencer A. Brown. (1992). The Relation of High Density Lipoprotein Cholesterol and Its Subfractions to Apolipoprotein A-l and Fasting Triglycerides: The Role of Environmental Factors. American Journal of Epidemiology. 136(5). 546–557.
18.
Steinberg, Seth M. & C.E. Davis. (1987). Comparison of nonparametric point estimators for interquantile differences in moderate sized samples. Communication in Statistics- Theory and Methods. 16(6). 1607–1616.
19.
Yoshizawa, Carl, Pranab Kumar Sen, & C.E. Davis. (1985). Asymptotic equivalence of the harrell-davis median estimator and the sample median. Communication in Statistics- Theory and Methods. 14(9). 2129–2136.
20.
Greene, Sandra B., et al.. (1977). Smoking habits and blood pressure change: A seven year follow-up. Journal of Chronic Diseases. 30(7). 401–413.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Dimitris Mavridis Breakdown of academic impact, for papers by Anton J.M. de Craen Breakdown of academic impact, for papers by Richard I. G. Holt Breakdown of academic impact, for papers by Stefan N. Willich Breakdown of academic impact, for papers by Charles Warlow Breakdown of academic impact, for papers by John E. Cornell Breakdown of academic impact, for papers by Jean‐François Dartigues Breakdown of academic impact, for papers by Philip B. Gorelick Breakdown of academic impact, for papers by Kathleen Hall Breakdown of academic impact, for papers by Wendy J. Mack